Technical Analysis for VTRS - Viatris Inc.

Grade Last Price % Change Price Change
B 15.73 -0.38% -0.06
VTRS closed down 0.38 percent on Friday, June 11, 2021, on 44 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Up Up
Historical VTRS trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Crossed Above 200 DMA Bullish -0.38%
Crossed Above 20 DMA Bullish -0.38%
Fell Below 20 DMA Bearish 1.81%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.81%
Narrow Range Bar Range Contraction 1.81%
NR7 Range Contraction 1.81%
Inside Day Range Contraction 1.81%
Older End-of-Day Signals for VTRS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day 3 days ago
Possible NR7 3 days ago
200 DMA Support 3 days ago
Down 1% 3 days ago
Fell Below 200 DMA 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Viatris Inc. Description

Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. The company provides medicines, such as Wixela, Inhub, ADVAIR DISKUS, glatiramer acetate injection, Copaxone, and over the counter products in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions; and support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, and EpiPen auto-injector; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; Trastuzumab injection; and Celebrex and anti-retrovirals names, as well as offers biosimilars franchises, including Fulphila, Ogivri, and Hulio. Viatris Inc. has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Canonsburg, Pennsylvania.


Classification

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Keywords: S&P 500 Biotechnology Drugs Infectious Diseases Health Care Active Pharmaceutical Ingredients HIV/Aids Biosimilar Adalimumab

Is VTRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.86
52 Week Low 12.94
Average Volume 9,333,415
200-Day Moving Average 15.72
50-Day Moving Average 14.43
20-Day Moving Average 15.49
10-Day Moving Average 15.46
Average True Range 0.33
ADX 27.93
+DI 27.15
-DI 12.42
Chandelier Exit (Long, 3 ATRs) 15.30
Chandelier Exit (Short, 3 ATRs) 15.86
Upper Bollinger Bands 16.10
Lower Bollinger Band 14.88
Percent B (%b) 0.7
BandWidth 7.86
MACD Line 0.28
MACD Signal Line 0.29
MACD Histogram -0.0174
Fundamentals Value
Market Cap 8.52 Billion
Num Shares 542 Million
EPS
Price-to-Sales 0.78
Price-to-Book 1.66
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.97
Resistance 3 (R3) 15.96 15.88 15.93
Resistance 2 (R2) 15.88 15.82 15.88 15.92
Resistance 1 (R1) 15.80 15.78 15.76 15.81 15.90
Pivot Point 15.72 15.72 15.70 15.72 15.72
Support 1 (S1) 15.64 15.66 15.60 15.65 15.56
Support 2 (S2) 15.56 15.62 15.56 15.54
Support 3 (S3) 15.48 15.56 15.53
Support 4 (S4) 15.49